Marshall Wace, LLP Quidel Ortho Corp Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Quidel Ortho Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 10,585 shares of QDEL stock, worth $412,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,585
Previous 143,585
92.63%
Holding current value
$412,391
Previous $4.77 Million
89.89%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding QDEL
# of Institutions
293Shares Held
68.1MCall Options Held
310KPut Options Held
134K-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.4MShares$366 Million0.26% of portfolio
-
Carlyle Group Inc. Washington, DC8.26MShares$322 Million56.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$236 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$191 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.2MShares$164 Million5.33% of portfolio
About QuidelOrtho Corp
- Ticker QDEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 66,952,900
- Market Cap $2.61B
- Description
- QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...